Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. [electronic resource]
Producer: 20050310Description: 1287-91 p. digitalISSN:- 1098-4275
- Blindness -- epidemiology
- Blood Transfusion -- statistics & numerical data
- Body Size -- drug effects
- Cerebral Palsy -- epidemiology
- Child Development -- drug effects
- Double-Blind Method
- Erythropoietin -- pharmacology
- Female
- Growth -- drug effects
- Hearing Disorders -- epidemiology
- Humans
- Infant
- Infant, Newborn
- Infant, Premature -- growth & development
- Infant, Very Low Birth Weight -- growth & development
- Iron -- pharmacology
- Male
- Psychomotor Disorders -- epidemiology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.